UCT943, a next generation <em>Plasmodium falciparum</em> PI4K inhibitor preclinical candidate for the treatment of malaria (Publications)
The 2-aminopyridine MMV048 was the first drug candidate inhibiting Plasmodium phosphatidylinositol 4-kinase (PI4K), a novel drug target for malaria, to enter clinical development. In an effort to iden
Challenges in malaria management and a glimpse at some nanotechnological approaches (Publications)
Malaria is a devastating infectious disease transmitted by mosquitoes, affecting millions of people and killing about half a million children each year. Despite tremendous progress in the control and
Travel Apps: applications et sites web en médecine des voyages (Publications)
Advancements in technology have led to the development of medical applications (Apps) and websites. Their use is especially relevant in the field of travel medicine, be it for travelers before their t